Fate Therapeutics FATE

$ 2.05 -7.66%

Quarterly report 2024-Q3
added 11-12-2024

Fate Therapeutics Balance Sheet 2011-2024 | FATE

Annual Balance Sheet Fate Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	61.7 M	48 M	-18.8 M	-	-72.9 M	-176 M	-62.1 M	-77.9 M	-46.6 M	-29.5 M	-52.3 M	-5.41 M	-1.55 M
Long Term Debt	97.4 M	104 M	109 M	-	-	12.4 M	14.8 M	2.5 M	10.7 M	18.1 M	-	1.73 M	3.59 M
Long Term Debt Current	6.18 M	5.63 M	5.58 M	3.36 M	1.69 M	2.44 M	-	8.19 M	7.55 M	1.55 M	1.73 M	-	-
Total Non Current Liabilities	-	-	-	-	29.7 M	25.3 M	17.1 M	6.71 M	16.5 M	18.3 M	135 K	59.1 M	54.9 M
Total Current Liabilities	39.1 M	114 M	81.3 M	85.6 M	27.8 M	27.3 M	11 M	15.2 M	13.4 M	4.58 M	4.6 M	-	-
Total Liabilities	-	-	-	-	57.5 M	52.6 M	28.1 M	21.9 M	29.9 M	22.9 M	4.74 M	63.9 M	58.5 M
Deferred Revenue	685 K	42.2 M	21.5 M	21.1 M	2.79 M	7.59 M	2.1 M	2.1 M	2.4 M	-	-	63 K	146 K
Retained Earnings	-1.21 B	-1.05 B	-769 M	-557 M	-384 M	-285 M	-219 M	-176 M	-142 M	-112 M	-86.5 M	-65.6 M	-51.4 M
Total Assets	506 M	706 M	921 M	622 M	302 M	213 M	105 M	95 M	68 M	51.2 M	55.6 M	11.1 M	7.85 M
Cash and Cash Equivalents	41.9 M	61.3 M	134 M	167 M	99.8 M	191 M	89 M	88.6 M	64.8 M	49.1 M	54 M	9.09 M	6.39 M
Book Value	506 M	706 M	921 M	622 M	245 M	160 M	77.2 M	73.2 M	38 M	28.3 M	50.8 M	-52.8 M	-50.7 M
Total Shareholders Equity	368 M	484 M	679 M	384 M	245 M	160 M	77.2 M	73.2 M	38 M	28.3 M	50.8 M	-52.8 M	-50.7 M

All numbers in USD currency

Quarterly Balance Sheet Fate Therapeutics

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	92.1 M	93.9 M	97.4 M	99 M	101 M	102 M	104 M	105 M	-	108 M	109 M	104 M	105 M	107 M	93.9 M	93.9 M	93.9 M	93.9 M	25.2 M	25.2 M	9.47 M	11 M	12.4 M	12.4 M	12.4 M	12.4 M	14.8 M	14.8 M	14.8 M	14.8 M	2.5 M	2.5 M	2.5 M	2.5 M	10.7 M	10.7 M	10.7 M	10.7 M	18.1 M	18.1 M	18.1 M	18.1 M	1.75 M	250 K	-	-	1.73 M	1.73 M	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	600 K	-	685 K	1.11 M	1.93 M	1.74 M	42.2 M	35.2 M	-	22.6 M	21.5 M	23.5 M	23 M	21 M	21.1 M	21.1 M	21.1 M	21.1 M	2.79 M	2.79 M	2.79 M	2.79 M	7.59 M	7.59 M	7.59 M	2.1 M	2.1 M	2.1 M	2.1 M	2.1 M	2.1 M	2.1 M	2.1 M	2.1 M	2.4 M	2.4 M	2.4 M	2.4 M	-	-	-	-	-	-	-	-	63 K	63 K	-	-	-	-	-	-
Retained Earnings	-1.35 B	-1.3 B	-1.21 B	-1.17 B	-1.12 B	-1.07 B	-1.05 B	-994 M	-	-835 M	-769 M	-700 M	-657 M	-602 M	-557 M	-557 M	-557 M	-557 M	-384 M	-384 M	-384 M	-384 M	-285 M	-285 M	-285 M	-285 M	-219 M	-219 M	-219 M	-219 M	-176 M	-176 M	-176 M	-176 M	-142 M	-142 M	-142 M	-142 M	-112 M	-112 M	-112 M	-112 M	-86.5 M	-86.5 M	-86.5 M	-	-	-	-	-	-	-	-	-
Total Assets	495 M	529 M	506 M	544 M	585 M	630 M	706 M	749 M	-	858 M	921 M	985 M	1.02 B	1.05 B	622 M	622 M	622 M	622 M	302 M	302 M	302 M	302 M	213 M	213 M	213 M	213 M	105 M	105 M	105 M	105 M	95 M	95 M	95 M	95 M	68 M	68 M	68 M	68 M	51.2 M	51.2 M	51.2 M	51.2 M	55.6 M	55.6 M	55.6 M	55.6 M	11.1 M	11.1 M	-	-	-	-	-	-
Cash and Cash Equivalents	37.9 M	36.9 M	41.9 M	33.3 M	46.8 M	42 M	61.3 M	82.1 M	55.3 M	64.7 M	134 M	129 M	76.7 M	106 M	167 M	167 M	167 M	167 M	99.8 M	99.8 M	99.8 M	99.8 M	191 M	191 M	191 M	191 M	89 M	89 M	89 M	89 M	88.6 M	88.6 M	88.6 M	88.6 M	64.8 M	64.8 M	64.8 M	64.8 M	49.1 M	49.1 M	49.1 M	49.1 M	54 M	54 M	54 M	54 M	9.09 M	9.09 M	-	-	6.39 M	-	-	-
Book Value	495 M	529 M	506 M	544 M	585 M	630 M	706 M	749 M	-	858 M	921 M	985 M	1.02 B	1.05 B	622 M	622 M	622 M	622 M	302 M	302 M	302 M	302 M	213 M	213 M	213 M	213 M	105 M	105 M	105 M	105 M	95 M	95 M	95 M	95 M	68 M	68 M	68 M	68 M	51.2 M	51.2 M	51.2 M	51.2 M	55.6 M	55.6 M	55.6 M	55.6 M	11.1 M	11.1 M	-	-	-	-	-	-
Total Shareholders Equity	362 M	397 M	368 M	403 M	438 M	477 M	484 M	518 M	580 M	633 M	679 M	730 M	752 M	790 M	384 M	384 M	384 M	384 M	245 M	245 M	245 M	245 M	160 M	160 M	160 M	160 M	77.2 M	77.2 M	77.2 M	77.2 M	73.2 M	73.2 M	73.2 M	73.2 M	38 M	38 M	38 M	38 M	28.3 M	28.3 M	28.3 M	28.3 M	50.8 M	50.8 M	50.8 M	50.8 M	-52.8 M	-52.8 M	-	-	-50.7 M	-	-	-

All numbers in USD currency